by Michael Nevradakis, Ph.D., Childrens Health Defense:
A military whistleblower released a series of documents revealing that the military began “liberally” administering remdesivir to service members who were suspected of having COVID-19 — months before the FDA approved the drug.
A military whistleblower released a series of documents revealing 601 deaths of military service members and a high rate of serious adverse events in clinical trials involving remdesivir, an antiviral commonly administered to COVID-19 patients during the pandemic.
TRUTH LIVES on at https://sgtreport.tv/
According to “The Remdesivir Papers,” some clinical trials were improperly run. In the case of at least one study, results were never made public. The whistleblower also alleged a widespread lack of informed consent for trial participants.
“Data derived from the Department of Defense [DOD] Joint Trauma System … by a military whistleblower offers a stark contrast to results of multiple clinical trials involving the liberal usage of remdesivir in military treatment facilities and other civilian facilities, as well as its potential contribution to, at minimum, hundreds of untimely deaths,” the documents state.
Yet according to the documents, the military began “liberally” administering remdesivir to service members who were suspected of having COVID-19 — months before the U.S. Food and Drug Administration (FDA) approved the drug.
The whistleblower, known by the pseudonym Daniel LeMay, shared the documents with investigative journalist J.M. Phelps, who published them last week in The Gateway Pundit.
In interviews with The Defender, LeMay and Phelps discussed the documents and their significance.
LeMay said the DOD’s Joint Trauma System is responsible for tracking “all sorts of patient data.” He told The Defender that the “initial trial depicted data manipulation in favor of remdesivir.”
He also said that based on his analysis of the data, several clinical trials did not have a true placebo group for which results could be compared with the remdesivir-receiving group. “The primary issue is with patient data. If we can’t verify the placebo group … then we can’t determine the actual efficacy of remdesivir.”
Reacting to the revelations, Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense, told The Defender:
“All of the information here needs to be made public and the public officials, including Tony Fauci, need to be held to account for the criminal acts associated with the fraudulent ‘trials’ of ivermectin and hydroxychloroquine that were tainted in order to preclude their use, and making remdesivir the standard of care despite the obvious data showing that it kills people.”
Former victims of the COVID-19 hospital protocols, which included administration of remdesivir, and advocates for those victims welcomed the documents’ release.
Gail Seiler, Texas chairperson of the FormerFedsGroup Freedom Foundation, escaped from a Texas hospital in 2021, where she was given remdesivir and listed as “Do Not Resuscitate” against her and her family’s stated wishes. She said “The Remdesivir Papers” only “scratch the surface as to the homicide toll in military hospitals.”
The documents “tell us that our government orchestrated the needless deaths of COVID patients who did not need to die,” Seiler said.
Charlene Delfico, New Jersey state chair of FormerFedsGroup, previously told The Defender that COVID-19 protocols, including remdesivir, implemented at a New Jersey hospital “ran roughshod” over her parents. She said the new documents “validate our grievances regarding remdesivir and the ‘out the window’ standard of care protocol put in place by our government.”
“The whistleblower highlights what we’ve been saying all along,” Delfico said. “This drug is dangerous, and in most cases, fatal. There’s been no transparency or oversight. This should enrage people and make them push for an immediate investigation by Congress.”
Read More @ ChildrensHealthDefense.org
